We are live on ! Find out more
LMAT icon

LeMaitre Vascular

227 hedge funds and large institutions have $1.16B invested in LeMaitre Vascular in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 67 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 67

30% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 23

9% more capital invested

Capital invested by funds: $1.06B → $1.16B (+$95.6M)

4.04% more ownership

Funds ownership: 87.51%91.55% (+4%)

3% more funds holding

Funds holding: 220227 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

25% less call options, than puts

Call options by funds: $874K | Put options by funds: $1.17M

Holders
227
Holders Change
+7
Holders Change %
+3.18%
% of All Funds
3.31%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
30
Increased
95
Reduced
67
Closed
23
Calls
$874K
Puts
$1.17M
Net Calls
-$295K
Net Calls Change
-$943K
Name Holding Trade Value Shares
Change
Change in
Stake
CJ
226
Caitlin John
Michigan
$57 +$52 +1 New
FFA
227
Farther Finance Advisors
California
$57 +$52 +1 New
State of New Jersey Common Pension Fund D
228
State of New Jersey Common Pension Fund D
New Jersey
-$2.32M -42,576 Closed
SG Americas Securities
229
SG Americas Securities
New York
-$884K -16,223 Closed
DFCM
230
Dark Forest Capital Management
Puerto Rico
-$755K -13,857 Closed
DTL
231
Dynamic Technology Lab
Singapore
-$621K -11,400 Closed
RJFSA
232
Raymond James Financial Services Advisors
Florida
-$552K -10,131 Closed
VI
233
Versor Investments
New York
-$548K -10,059 Closed
Voloridge Investment Management
234
Voloridge Investment Management
Florida
-$547K -10,037 Closed
ADIM
235
Alpha DNA Investment Management
Maryland
-$516K -9,475 Closed
AWM
236
AE Wealth Management
Kansas
-$461K -8,470 Closed
M1FG
237
Mach-1 Financial Group
Arkansas
-$457K -8,387 Closed
XT
238
XTX Topco
Cayman Islands
-$438K -8,033 Closed
Tudor Investment Corp
239
Tudor Investment Corp
Connecticut
-$413K -7,574 Closed
EA
240
Ellsworth Advisors
Ohio
-$306K -6,344 Closed
PAM
241
Panagora Asset Management
Massachusetts
-$315K -5,791 Closed
MHI
242
Miller Howard Investments
New York
-$254K -4,666 Closed
EGM
243
Engineers Gate Manager
New York
-$223K -4,089 Closed
BCM
244
BluePath Capital Management
Georgia
-$31.4K -577 Closed
Point72 Asset Management
245
Point72 Asset Management
Connecticut
-$28.3K -520 Closed
OA
246
Operose Advisors
Wisconsin
-$16.3K -299 Closed
BTI
247
Blue Trust Inc
Georgia
-$7K -110 Closed
PFBT
248
Parkside Financial Bank & Trust
Missouri
-$5.18K -95 Closed
FCA
249
FinTrust Capital Advisors
South Carolina
-$2.4K -44 Closed
SS
250
Sunbelt Securities
Texas
-$1.09K -20 Closed

LMAT Hedge Fund Activity: Q4 2023 in Review

227 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2023, worth a combined $1.16B — up 9% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new LMAT positions and 23 closed out — a net gain of 7 holders — while 95 added to existing stakes and 67 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $17.6M. The largest seller was State of New Jersey Common Pension Fund D, exiting entirely with an estimated $2.32M sold.

  • 227 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2023, up from 220 in Q3 2023.
  • Funds reported $1.16B of LeMaitre Vascular stock for Q4 2023, up 9% quarter-over-quarter.
  • 30 funds opened new LeMaitre Vascular positions in Q4 2023 and 23 closed out, a net change of +7 holders.
  • The largest LeMaitre Vascular buyer in Q4 2023 was Morgan Stanley, an estimated $17.6M added.
  • The largest LeMaitre Vascular seller in Q4 2023 was State of New Jersey Common Pension Fund D, an estimated $2.32M sold.

Based on aggregated 13F filings for Q4 2023.